Logo

MBio Lands $218K NSF Grant for Water Toxin Testing

Jul 08, 2016 | staff reporter

NEW YORK (GenomeWeb) – Boulder, Colorado-based MBio Diagnostics has received a $217,702 grant from the National Science Foundation to develop toxin testing technology.

The grant funds development of a portable platform to detect algal bloom toxins using the firm's multiplexed fluorescence immunoassay Array System and LightDeck fluorescence assay illumination technology.

"MBio has demonstrated a unique, portable testing platform that delivers a panel of freshwater and marine toxin test results in a matter of minutes in an easy-to-use format," the firm said in a statement.

MBio CTO Michael Lochhead added that the grant would help the firm develop the technology into a commercial product.

The grant is the latest product development news from MBio. The firm also signed a deal with Roka Bioscience in December 2015 to develop food safety testing technology.

Filed under

Applied Markets: Ag-Bio, Veterinary, Forensics, Food Safety, & Environmental Testing
Microarrays & Multiplexing
Immunoassays
Research Funding
research grant
NSF
Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.